Datumama, Vivian .
HRN: 20-39-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2025
CEFUROXIME 500MG (TAB)
05/27/2025
06/02/2025
PO
500 Mg
BID
Sp Completion Curettage
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines